jejuni was the predominant species (78%), with C. coli, C. fetus, C. lari, and C. upsaliensis isolated less frequently. Campylobacter infection prevailed throughout the year, with no seasonality. The C. jejuni isolation rate was significantly higher (10.0%; p<0.001) for children <5 years of age who had diarrhea than for persons in other age groups (3.7%). Although we used the culture method, which is the standard for screening fecal samples, some molecular methods, such as PCR and real-time PCR, are now used for screening Campylobacter spp. from fecal samples on the Indian subcontinent (4, 5 have stated that introduction of fluoroquinolones for use in veterinary practice has been associated with a dramatic rise in Campylobacter strains showing resistance to these drugs (9) . Increasing antimicrobial drug resistance limits the number of therapeutic options, which makes empirical treatment more difficult. Therefore, constant monitoring of Campylobacter susceptibility to antimicrobial agents is essential. We could not detect any allele of plasmid-mediated quinolone resistance genes (qnr) among C. jejuni isolates and the different class of mobile genetic elements that generally carry the antimicrobial resistance gene cassettes. However, we found that most of the C. jejuni isolates had a mutation in the quinolone-resistance determining region of gyrA (Thr-86 to Ile), which led the isolates to become resistant for quinolone and fluoroquinolones.
Recent microbiome analysis of the gut of a malnourished child residing in an urban slum in Kolkata showed 35 times more Campylobacter bacteria than in healthy child in the same setting (10) . This finding suggests that intestinal inflammation may directly influence malabsorption of nutrients. Hence, it is essential to examine the effect of Campylobacter infection in the developing world in the context of many recent developments in the human gut microbiome. To the Editor: Among Enterobacteriaceae, Verona integron-encoded metallo-β-lactamase 1 (VIM-1) has been found only in Klebsiella pneumoniae in North America (1). We report 4 VIM-1-producing Enterobacteriaceae isolated from 4 patients at 3 hospitals in Ontario, Canada.
Patient 1, a 61-year-old man, was initially hospitalized in Italy for presumed pneumonia and was treated with levofloxacin during his 6-month stay in Italy. Upon returning to Ontario, Canada, he was admitted to hospital 1 in August 2010 because of diabetic ketoacidosis and began empiric treatment with metronidazole and gentamicin. Urine cultures were positive for a carbapenem-resistant Escherichia coli (strain GN531). Two days later, the patient had a fever and a blood culture was positive for E. coli (strain GN532), which was also resistant to carbapenems. During his hospitalization, the patient was isolated and received droplet precaution because of his travel history until he was discharged home.
Patient 2, a 76-year-old man, was admitted to hospital 2 in May 2011 because of a recurrent urinary tract
